KRAS Inhibitors Drugs Market Forecast Clinical Trials Companies FDA Approval Insight
11 juil. 2024 07h27 HE
|
KuicK Research
Delhi, July 11, 2024 (GLOBE NEWSWIRE) -- Global KRAS Inhibitors Market and Clinical Trials Future Outlook 2030 Report Highlights: Global KRAS Inhibitors Sales Growth In 2023: 10%Global KRAS...
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress
09 mai 2022 16h02 HE
|
Revolution Medicines, Inc.
Lead RAS(ON) Inhibitor drug candidates RMC-6236 (RASMULTI) and RMC-6291 (KRASG12C) approaching the clinic RMC-4630-03 Phase 2 trial evaluating RAS Companion Inhibitor RMC-4630 (SHP2) in combination...